Founded at the Abramson Cancer Center at the University of Pennsylvania

PC3I Wins $5.7 Million NCI Grant for New Cancer Telehealth Research Center of Excellence Supported by White House Leadership

The University of Pennsylvania (Penn) Telehealth Research Center of Excellence (Penn TRACE), based at the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center, is one of four National Cancer Institute (NCI) Telehealth Research Centers of Excellence dedicated to advancing the nation’s telehealth research agenda focused on improving cancer-related care and outcomes. With support from the White House Cancer Moonshot, Penn TRACE applies insights from communication science and behavioral economics to design and test innovative telehealth approaches to improve effectiveness and equity across the cancer care continuum, with an emphasis on advancing health equity and addressing the digital divide.

Three PC3I Innovation Faculty will lead the center as principal investigators: Katharine Rendle, PhD, MSW, MPH; Anil Vachani, MD, MS; and Justin Bekelman, MD, Director of PC3I.

Read the full Penn Medicine press release as well as the National Cancer Institute press release.

Learn more about Penn TRACE.

Related News